Shots:
Samsara Biocapital is a California-based venture capital and registered investment adviser investing across early to post-IPO stages in healthcare, life sciences, oncology, and digital health, with a portfolio of 70+ companies including Scholar Rock and PepGen
The firm made 30 investments across PIPE (43%), Series B (23%), and other rounds, with notable deals such…
Shots:
A California-based venture capital fund, Samsara Biocapital partners with medical companies and scientists to infuse cutting-edge innovations in medicines
In 2023, Samsara participated in five funding rounds and invested around $2.3B to add 19 companies to its portfolio
For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com …

